OCUL - Ocular Therapeutix - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

OCUL is currently covered by 10 analysts with an average price target of $26.19. This is a potential upside of $20.62 (370.2%) from yesterday's end of day stock price of $5.57.

Our record on OCUL covers 21 analysts since 2008; 10 cover it today. Of the 169 price targets those analysts set on OCUL, 93 were reached (55%). The highest performance score on OCUL belongs to Tara Bancroft of TD Cowen: 3.47, with 5 of 6 targets met in 110 days on average. The latest calls: Yi Chen of H.C. Wainwright kept the target at $28 with a Buy rating on 16 Nov 2026; Serge Belanger of Needham kept the target at $18 with a Buy rating on 18 Oct 2026; Andreas Argyrides of Chardan Capital kept the target at $23 with a Buy rating on 1 Oct 2026. Figures as of 18 Nov 2026.

Ocular Therapeutix's activity chart (see below) currently has 191 price targets and 179 ratings on display. The stock rating distribution of OCUL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 44.42% of the time, taking 361.34 days on average.

Highest price target for OCUL is $34, Lowest price target is $18, average price target is $26.19.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT. First documented stock forecast 10-Mar-2015.

Best performing analysts who are covering OCUL - Ocular Therapeutix:

Elemer Piros Biren Amin Jonathan Wolleben Serge Belanger Joseph Catanzaro

Currently out of the existing stock ratings of OCUL, 26 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Oct-2021

$28

$22.43 (402.69%)

$28

4 days ago
(16-Nov-2026)

Buy Since 11-Mar-2025

$18

$12.43 (223.16%)

$18

1 months 2 days ago
(19-Oct-2026)

4/9 (44.44%)

$11.71 (186.17%)

214

Buy Since 25-Jun-2026

$23

$17.43 (312.93%)

$23

1 months 19 days ago
(02-Oct-2026)

0/4 (0%)

$16.04 (230.46%)

Buy Since 21-Apr-2023

$30

$20.16 (204.88%)

$24

5 months 3 days ago
(18-Jun-2026)

0/6 (0%)

$20.57 (218.13%)

Buy Since 09-Dec-2025

$30

$20.16 (204.88%)

$30

6 months 15 days ago
(06-May-2026)

0/2 (0%)

$20.29 (208.96%)

Show more analysts

Please expand the browser size to see the chart

What is OCUL (Ocular Therapeutix) average time for price targets to be met?

On average it took 361 days for the stock forecasts to be reached, with an average price target met ratio of 44.42%.

Which analyst most recently updated their price target on OCUL (Ocular Therapeutix)?

Yi Chen

Which analyst has the most public recommendations on OCUL (Ocular Therapeutix)?

Yi Chen works at HC WAINWRIGHT and has 17 price targets and 10 ratings on OCUL

Which analyst is the currently most bullish on OCUL (Ocular Therapeutix)?

Jonathan Wolleben with the highest potential upside of $28.43

Which analyst is the currently most reserved on OCUL (Ocular Therapeutix)?

Elemer Piros with the lowest potential downside of $1.43
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?